Blood donor return behavior in South Africa and the United States before and during the COVID-19 pandemic

Transfusion. 2024 Aug;64(8):1492-1502. doi: 10.1111/trf.17934. Epub 2024 Jun 28.

Abstract

Background: Studies preceding the COVID-19 pandemic found that slower time-to-return was associated with first-time, deferred, and mobile drive blood donors. How donor return dynamics changed during the COVID-19 pandemic is not well understood.

Methods: We analyzed visits by whole blood donors from 2017 to 2022 in South Africa (SA) and the United States (US) stratified by mobile and fixed environment, first-time and repeat donor status, and pre-COVID19 (before March 2020) and intra-COVID19. We used Kaplan-Meier curves to characterize time-to-return, cumulative incidence functions to analyze switching between donation environments, and Cox proportional hazards models to analyze factors influencing time-to-return.

Results: Overall time-to-return was shorter in SA. Pre-COVID19, the proportion of donors returning within a year of becoming eligible was lower for deferred donors in both countries regardless of donation environment and deferral type. Intra-COVID19, the gap between deferred and non-deferred donors widened in the US but narrowed in SA, where efforts to schedule return visits from deferred donors were intensified, particularly for non-hemoglobin-related deferrals. Intra-COVID19, the proportion of donors returning within a year in SA was higher for deferred first-time donors (>81%) than for successful first-time donors (80% at fixed sites; 69% at mobile drives).

Conclusions: The pandemic complicated efforts to recruit new donors and schedule returning visits after completed donations. Concerted efforts to improve time-to-return for deferred donors helped mitigate donation loss in SA during the public health emergency.

Keywords: COVID‐19 pandemic; blood donor management; donor deferral; donor recruitment and retention.

MeSH terms

  • Adult
  • Blood Donors* / statistics & numerical data
  • COVID-19* / epidemiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • SARS-CoV-2*
  • South Africa / epidemiology
  • United States / epidemiology